Results     22-May-18
Announcements
Astrazeneca Pharma India reports standalone net profit of Rs 3.22 crore in the March 2018 quarter
Sales rise 30.27% to Rs 150.73 crore
Net profit of Astrazeneca Pharma India reported to Rs 3.22 crore in the quarter ended March 2018 as against net loss of Rs 9.56 crore during the previous quarter ended March 2017. Sales rose 30.27% to Rs 150.73 crore in the quarter ended March 2018 as against Rs 115.71 crore during the previous quarter ended March 2017.

For the full year,net profit rose 29.23% to Rs 25.91 crore in the year ended March 2018 as against Rs 20.05 crore during the previous year ended March 2017. Sales rose 5.02% to Rs 571.00 crore in the year ended March 2018 as against Rs 543.70 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear Ended
 Mar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.
Sales150.73115.71 30 571.00543.70 5
OPM %10.130.60 -8.116.79 -
PBDT17.611.69 942 58.5451.33 14
PBT14.06-1.99 LP 43.8035.50 23
NP3.22-9.56 LP 25.9120.05 29

Previous News
  Astrazeneca Pharma India fixes record date for final dividend
 ( Market Beat - Reports 26-Jun-24   09:51 )
  Astrazeneca Pharma India standalone net profit rises 172.47% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   17:08 )
  Board of Astrazeneca Pharma India recommends Final Dividend
 ( Corporate News - 28-May-22   10:09 )
  AstraZeneca set to launch Osimertinib 40mg/80mg film coated tablets
 ( Corporate News - 10-Mar-21   16:33 )
  Astrazeneca Pharma India to table results
 ( Corporate News - 02-Aug-22   10:54 )
  Volumes soar at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 07-Feb-19   11:00 )
  AstraZeneca Pharma receives DCGI approval for launch of Benralizumab (Fasenra™) in India
 ( Corporate News - 21-Dec-20   08:55 )
  Astrazeneca Pharma India to declare Quarterly Result
 ( Corporate News - 02-Aug-21   17:55 )
  Astrazeneca Pharma India AGM scheduled
 ( Corporate News - 12-Jul-19   16:40 )
  AstraZeneca Pharma sizzles after turnaround Q3 result
 ( Hot Pursuit - 07-Feb-19   09:24 )
  Astrazeneca Pharma India standalone net profit rises 3322.50% in the September 2017 quarter
 ( Results - Announcements 07-Nov-17   16:18 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top